NCT05965882

Brief Summary

The registry study aims to discover biomarkers for accurate classification and risk assessment of ischemic heart disease.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2016

Completed
7.1 years until next milestone

First Submitted

Initial submission to the registry

July 20, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 28, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

January 29, 2024

Status Verified

January 1, 2024

Enrollment Period

8 years

First QC Date

July 20, 2023

Last Update Submit

January 25, 2024

Conditions

Cardiovascular Diseases

Keywords

Ischemic heart disease

Outcome Measures

Primary Outcomes (1)

  • Number of hospitalizations for acute heart failure (HF)

    Unplanned emergency visits or hospitalizations leading to HF deterioration were defined as hospitalizations for HF

    These data is collected during follow-up visit at 3/6/12/24/36/48 months after discharge

Secondary Outcomes (1)

  • Number of major adverse cardiovascular events (MACE)

    These data is collected during follow-up visit at 3/6/12/24/36/48 months after discharge

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Partients with ischemic heart disease accorrding to Inclusion and exclusion criteria.

You may qualify if:

  • Aged 18 years or older.
  • Previous ischemic symptoms/signs or electrocardiographic ischemic changes and.
  • \>70% stenosis of at least one epicardial coronary artery on angiography or a history of myocardial infarction or coronary revascularization.

You may not qualify if:

  • Current known inability to follow instructions or comply with follow-up procedures.
  • Eligible patients without informed consent form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Anzhen Hospital

Beijing, Beijing Municipality, 100029, China

RECRUITING

MeSH Terms

Conditions

Cardiovascular DiseasesMyocardial Ischemia

Condition Hierarchy (Ancestors)

Heart DiseasesVascular Diseases

Study Officials

  • Jie Du, phD

    The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart,Lung and Blood Vessel Diseases

    STUDY DIRECTOR

Central Study Contacts

Yuan Wang, PhD

CONTACT

13910161443wangyuan980510@163.com

Yangkai Fan, PhD

CONTACT

15010188587fan@mail.ccmu.edu.cn

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 20, 2023

First Posted

July 28, 2023

Study Start

June 1, 2016

Primary Completion

June 1, 2024

Study Completion

June 1, 2024

Last Updated

January 29, 2024

Record last verified: 2024-01

Locations

CN(1)